Adolescents with congenital heart diseases

Cardiology Journal

Volumn 17, Issue 1, 2010, Pages 11-19

  Trojnarska, Olga ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Arrhythmia; Cyanosis; Heart failure; Impulse formation and conduction disorders; Pregnancy

Indexed keywords

ALDOSTERONE ANTAGONIST; AMBRISENTAN; AMIODARONE; ANTICOAGULANT AGENT; BERAPROST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; COUMARIN DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FERROUS SULFATE; ILOPROST; INFLUENZA VACCINE; NITRIC OXIDE; PNEUMOCOCCUS VACCINE; PROSTACYCLIN; SILDENAFIL; SITAXSENTAN; TADALAFIL; UNIPROST;

ADOLESCENT DISEASE; ANESTHESIST; ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; ATRIOVENTRICULAR BLOCK; CATHETER ABLATION; CONGENITAL HEART MALFORMATION; CYANOSIS; DELIVERY; EBSTEIN ANOMALY; EVIDENCE BASED MEDICINE; EXTRACORPOREAL CIRCULATION; FALLOT TETRALOGY; FONTAN PROCEDURE; HEALTH CARE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LUNG TRANSPLANTATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VALVE REPLACEMENT; HEART VENTRICLE ARRHYTHMIA; HUMAN; IRON DEFICIENCY ANEMIA; KNOWLEDGE; LUNG INFECTION; MARFAN SYNDROME; MUSTARD OPERATION; PATHOPHYSIOLOGY; PEDIATRIC SURGERY; PHLEBOTOMY; PREGNANCY; PULMONARY HYPERTENSION; RECURRENT DISEASE; REVIEW; STROKE; SURVIVAL; THROMBOSIS;

ADOLESCENT; ARRHYTHMIAS, CARDIAC; CYANOSIS; FEMALE; HEART BLOCK; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; INCIDENCE; PATIENT CARE TEAM; PREGNANCY;

EID: 75749122638     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Warnes CA, Liberthson R, Danielson GK et al. Tasc force 1: The changing profile of congenital heart disease in adult life. J Am Coll Cardiol, 2001; 37: 5: 1161-1198.
2. Somerville J. Grown-up congenital heart (GUCH) disease: Current needs and provisions of service for adolescents and adults with congenital heart disease in UK. Heart, 2002; 88: (suppl. 1): 11-14.
3. Deanfield J, Thaulow E, Warnes C et al. Guidelines. Management of grown up congenital heart disease of the ESC. Eur Heart J, 2003; 24: 1035-1084.
4. Trojnarska O. Opieka kardiologiczna nad dorosłymi pacjentami z wadami wrodzonymi serca na terenie zachodniej Polski. Folia Cardiol, 2006; 13: 2: 140-146.
5. Marelli AJ, Mackie AS, Ionesco-Ittu R et al. Congenital heart disease in general population. Changing prevalence and age distribution. Circulation, 2007; 115: 163-172.
6. Daebritz SH. Update in adult congenital cardiac surgery. Pediatr Cardiol, 2007; 28: 96-104.
7. Mackie AS, Pilote L, Ionescu-Ittu R et al. Health care resource in adults with congenital heart disease. Am J Cardiol, 2007; 99: 839-843.
8. Billett J, Cowie MR, Gatzoulis MA et al. Comorbidity, healthcare utilisation and process of care measures in patients with congenital heart diseases in the UK: Cross-sectional, population-based study with case-control analysis. Heart, 2008; 94: 1194-1199.
9. Dearani JA, Connoly HM, Martinez R et al. Caring for adults with congenital cardiac disease: successes and challenges for 2007 and beyond. Cardiol Young, 2007; 17: 2: 87-96.
10. Hirsch JC, Birkmeyer JD. Growing pains the challenges of managing congenital heart disease after childhood. Circulation, 2008; 118: 2321-2322.
11. Graham TP. The year in congenital heart disease. J Am Coll Cardiol, 2008; 52: 18: 1492-1499.
12. Mahle WT, Krishbom PM, Kanter KR et al. Cardiac surgery in adults performed at children's hospitals: trends and outcomes. J Thorac Cardiovasc Surg, 2008; 136: 2: 307-311.
13. Monro JL. The changing state of surgery for adult congenital heart disease. Heart, 2005; 91: 193-140.
14. Karamlou T, Diggs BS, Person T et al. National practice patterns for management of adult congenital heart disease. Operation by pediatric heart surgeons decreases in-hospital death. Circulation, 2008; 118: 2345-2352.
15. Warnes CA. The adult with congenital heart disease. Born to be bed? J Am Coll Cardiol, 2005; 46: 1-8.
16. Perlof JK, Child CA. Congenital heart disease in adults. W.B. Saunders Company, Philadelphia 1998.
17. Walsh EP, Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation, 2007; 115: 534-545.
18. Warnes CA. Transposition of the great arteries. Circulation, 2006; 114: 2699-2709.
19. Khairy P, Poirier N, Mercier LA. Univentricular heart. Circulation, 2007; 115: 800-812.
20. Therrien J, Siu SC, Harris L. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation, 2001; 103: 2489-2494.
21. Gatzoulis MA, Walters J, McLaughlin PR. Late arrhythmia in adults with Mustard procedure for transposition of the great arteries: a surrogate marker for right ventricle dysfunction? Heart, 2000; 84: 409-415.
22. Trojnarska O, Szyszka A, Oko-Sarnowska Z et al. Nadkomorowe zaburzenia rytmu u dorosłych pacjentów po całkowitej korekcji tetralogii Fallota. Folia Cardiol, 2004; 11: 2: 153-159.
23. Sommer RJ, Hijazi ZM, Rhodes JF. Pathophysiology of congenital heart disease in the adult. Complex congenital heart disease. Circulation, 2008; 117: 1340-1350.
24. Aboulhosn J, Child JS. Left ventricular outflow obstruction. Circulation, 2006; 114: 2412-2422.
25. Mijazaki A, Ohuchu H, Kurosaki K et al. Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital hart disease. Circ J, 2008; 72: 1998-2003.
26. Walsh EP. Interventional electrophysiology in patients with congenital heart disease Circulation, 2007; 115: 3224-3234.
27. Hansky B, Blinz U, Peuster M et al. Endocardial pacing after Fontan-type procedures. Pacing Clin Electrophysiol, 2005; 28: 140-148.
28. Chetaille P, Walsh EP, Triedman JK. Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Heart Rhythm, 2004; 1: 168-173.
29. Gatzoulis MA, Balaji S, Webber SA et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: A multicenter study. Lancet, 2000; 356: 975-981.
30. Khairy P, Landzberg MJ, Gatzoulis MA et al. Value of programmed ventricular stimulation after tetralogy of Fallot repair. Circulation, 2004; 109: 1994-2000.
31. Van Hare GF. Substrate mapping and catheter ablation of ventricular tachycardia after right ventriculotomy. Circulation, 2007; 116: 2236-2237.
32. Stephenson EA, Batara AS, Knilans TK et al. A multicenter experience with novel implantable cardioverter defibrilator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol, 2006; 17: 41-46.
33. Batara AS, Balaji S. Pacing in adults with congenital heart disease. Export Rev Cardiovasc Ther, 2006; 4: 5: 665-670.
34. Trojnarska O, Stanek K, Mitkowski P et al. Stała stymulacja serca u dorosłych pacjentów z zadami wrodzonymi serca. Folia Cardiol, 2004; 11: 4: 299-307.
35. Gregoratos G, Abrams J, Epstein AE et al. ACC/AHA/NASPE 2002 Guideline Update for implantation of cardiac pacemaker and arrhythmia devices. J Am Coll Cardiol, 2002; 40: 1703-1719.
36. Bolger AP, Gatzoulis MA. Towards defining heart failure in adults with congenital heart disease. Int J Cardiol, 2004; 97: 15-23.
37. Fredriksen PM, Veldtman G, Heachter S et al. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol, 2001; 87: 310-314.
38. Trojnarska O, Szyszka A, Gwizdała A et al. The BNP concentrations and exercise capacity assessment with cardiopulmonary stress test in patients after surgical repair of tetralogy of Fallot. Int J Cardiol, 2006; 110: 86-92.
39. Diller GP, Dimopaulos K, Okano D et al. Exercise intolerance in adult congenital heart disease. Comparative severity, correlates and prognostic implications. Circulation, 2005; 112: 828-835.
40. Trojnarska O. Heart failure in the adult patients with congenital heart disease. Cardiol J, 2007; 14: 2: 127-137.
41. Dore A, Houde C, Chan KL et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricle: A multicenter, randomized, placebo-controlled clinical trial. Circulation, 2005; 112: 2411-2416.
42. Shaddy RE, Boucek MM, Hsu DY et al. Carvedilol in children with heart failure. JAMA, 2007; 298: 1171-1179.
43. Lester SJ, McElhinney DB, Viloria E et al. Effects of losartan in patients with systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. Am J Cardiol, 2001; 88: 1314-1316.
44. Ringel RE, Peddy SB. Effect of high dose spironolactone on protein loosing enteropathy in patients with Fontan palliation of complex congenital heart disease. Am J Cardiol, 2003; 91: 1031-1032.
45. Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare CG, Rosenthal DN. Electrical resynchronization: A novel therapy for the failing right ventricle. Circulation, 2003; 107: 2287-2289.
46. Iglessis I, Landzberg MJ. Interventional catheterization in adult congenital heart disease. Circulation, 2007; 115: 1622-1633.
47. Fawsy ME, Awad M, Hassan W et al. Long-term-outcome (up to 15 years) of balloon angioplasty of discrete native coarctation of the aorta in adolescents and adults. J Am Coll Cardiol, 2004; 43: 1062-1067.
48. Gamba A, Merlo M, Fiocchi R et al. Heart transplantation in patients with previous Fontan operation. J Thorac Cardiovasc Surg, 2004; 127: 555-562.
49. Oechslin EN, Harrison DA, Connely MS et al. Mode of death in adults with congenital heart disease. Am J Cardiol, 2000; 86: 1111-1116.
50. Broberg CX, Bax BE, Okonko DO et al. Blood viscosity and its relationship to iron deficiency, symptoms and exercise capacity in adults with congenital cyanotic heart disease. J Am Coll Cardiol, 2006; 48: 356-365.
51. Perlof JJ, Rosove MH, Child JS, Wright GB. Adults with cyanotic congenital heart disease: Hematological management. Ann Int Med, 1988; 109: 406-416.
52. Silversides CK, Granton JT, Konen EM, Hart MAM, Webb GDM, Therrien J. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol, 2006; 42: 1982-1987.
53. Galie N, Manes A, Pallzini M et al. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger syndrome. Drugs, 2008; 66: 8: 1049-1066.
54. Sandoval J, Aguirre JS, Pulido T. Nocturnal oxygen therapy with patient with Eisenmenger syndrome. Am J Respir Crit Care Med, 2001; 164: 1682-1687.
55. Diler GP, Gatzoulis MA. Pulmonary vascular disease in adult patients with congenital heart disease. Circulation, 2007; 115: 1039-1050.
56. Diller GP, Dimopoulus K, Kaya MG et al. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease. Heart, 2007; 93: 974-976.
57. Presbitero P, Somerville J, Stone S et al. Pregnancy in cyanotic congenital heart disease (outcome of mother and fetus). Circulation, 1994; 98: 2673-2376
58. Siu SS, Sermer S, Colman J et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation, 2001; 104: 515-521.
59. Meijboom LJ, Vos FE, Timmermans J et al. Pregnancy and aortic root growth in the Marfan syndrome: A prospective study. Eur Heart J, 2005; 26: 914-920.
60. Trojnarska O, Cieśliński A. Wady serca wrodzone i nabyte podczas cia̧ży. Choroby układu kra̧żenia a cia̧ża. In: Bréborowicz GH, Tykarski A eds. Ośrodek Wydawnictw Naukowych, Poznań 2007: 87-103.
61. Fesslova VME, Villa L, Chessa et al. Int J Cardiol, 2009; 131: 257-264.
62. Trojnarska O, Siwińska A, Markwitz W et al. Cia̧ża i poród u pacjentek z wrodzonymi wadami serca. Folia Cardiol, 2004; 11: 6: 415-423.
63. Thorne SA. Pregnancy in heart disease. Heart, 2004; 90: 540-546.
64. Thorne S, MacGregor A, Nelson-Piercy C. Risk of contraception and pregnancy in heart disease. Heart, 2006; 92: 1520-1525.
65. Silka MJ, Hardy BG, Meneshe VD et al. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol, 1998; 32: 245-251.
66. Price S, Jagger SI, Jordan S et al. Adult congenital heart disease: Intensive care management and outcome prediction. Intensive Care Med, 2007; 33: 652-659.
67. Berdat PA, Immer F, Pfammater JP et al. Reoperation in adults with congenital heart disease: analysis of early outcome. Intern J Cardiol, 2004; 93: 239-245.